R01 CA068458/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2001	1
2002	1
2006	3
2007	2
2008	4
2009	7
2010	5
2011	2
2012	5
2013	5
2014	6
2015	4
2016	7
2017	3
2018	16
2019	6
2020	6
2021	10
2022	5
2024	1

1

Caligiuri MA. Caligiuri MA. Blood. 2008 Aug 1;112(3):461-9. doi: 10.1182/blood-2007-09-077438. Blood. 2008. PMID: 18650461 Free PMC article. Review.

2

The Broad Spectrum of Human Natural Killer Cell Diversity.

Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA. Freud AG, et al. Immunity. 2017 Nov 21;47(5):820-833. doi: 10.1016/j.immuni.2017.10.008. Immunity. 2017. PMID: 29166586 Free PMC article. Review.

3

Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.

Ma S, Caligiuri MA, Yu J. Ma S, et al. Trends Immunol. 2022 Oct;43(10):833-847. doi: 10.1016/j.it.2022.08.004. Epub 2022 Sep 1. Trends Immunol. 2022. PMID: 36058806 Free PMC article. Review.

4

The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.

Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang LS, Sun JC, Chen J, Caligiuri MA, Yu J. Ma S, et al. J Exp Med. 2021 Aug 2;218(8):e20210279. doi: 10.1084/jem.20210279. Epub 2021 Jun 23. J Exp Med. 2021. PMID: 34160549 Free PMC article.

5

Editorial: Natural Killer Cells in Tissue Compartments.

Vitale M, Caligiuri MA, Sivori S. Vitale M, et al. Front Immunol. 2020 Feb 20;11:258. doi: 10.3389/fimmu.2020.00258. eCollection 2020. Front Immunol. 2020. PMID: 32153578 Free PMC article. No abstract available.

6

An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.

Ma R, Lu T, Li Z, Teng KY, Mansour AG, Yu M, Tian L, Xu B, Ma S, Zhang J, Barr T, Peng Y, Caligiuri MA, Yu J. Ma R, et al. Cancer Res. 2021 Jul 1;81(13):3635-3648. doi: 10.1158/0008-5472.CAN-21-0035. Epub 2021 May 18. Cancer Res. 2021. PMID: 34006525 Free PMC article.

7

Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy.

Cao X, Chen J, Li B, Dang J, Zhang W, Zhong X, Wang C, Raoof M, Sun Z, Yu J, Fakih MG, Feng M. Cao X, et al. Sci Adv. 2022 Mar 18;8(11):eabl9171. doi: 10.1126/sciadv.abl9171. Epub 2022 Mar 18. Sci Adv. 2022. PMID: 35302839 Free PMC article.

8

Obesity, Inflammation, and Cancer.

Deng T, Lyon CJ, Bergin S, Caligiuri MA, Hsueh WA. Deng T, et al. Annu Rev Pathol. 2016 May 23;11:421-49. doi: 10.1146/annurev-pathol-012615-044359. Annu Rev Pathol. 2016. PMID: 27193454 Review.

9

The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.

Dong W, Wu X, Ma S, Wang Y, Nalin AP, Zhu Z, Zhang J, Benson DM, He K, Caligiuri MA, Yu J. Dong W, et al. Cancer Discov. 2019 Oct;9(10):1422-1437. doi: 10.1158/2159-8290.CD-18-1259. Epub 2019 Jul 24. Cancer Discov. 2019. PMID: 31340937 Free PMC article.

10

Cellular pathways in the development of human and murine innate lymphoid cells.

Scoville SD, Freud AG, Caligiuri MA. Scoville SD, et al. Curr Opin Immunol. 2019 Feb;56:100-106. doi: 10.1016/j.coi.2018.11.003. Epub 2018 Dec 19. Curr Opin Immunol. 2019. PMID: 30579240 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year